Jackie Fairley
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Jackie Fairley
Chief Executive, Executive Director / Starpharma Holdings
Most Notable Role
Dr Jacinth Fairley has been the chief executive of Starpharma Holdings since 2006.
Dr Fairley has more than 30 years of operational experience in the pharmaceutical and biotechnology industries, working in business development and senior management roles in companies including CSL and Faulding/Hospira (now part of Pfizer).
Dr Fairley is also chair of the Invest Victoria Advisory Board, a board member of the Melbourne Business School, and an advisor to the Carnegie Innovation Fund.
Dr Fairley has more than 30 years of operational experience in the pharmaceutical and biotechnology industries, working in business development and senior management roles in companies including CSL and Faulding/Hospira (now part of Pfizer).
Dr Fairley is also chair of the Invest Victoria Advisory Board, a board member of the Melbourne Business School, and an advisor to the Carnegie Innovation Fund.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 586th | Mirrabooka Investments | 21% | 9% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Mirrabooka Investments | $16.0m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Chief Executive, Executive Director, Starpharma Holdings | 03 Nov 2020 |
| NEW ROLE: Non-Executive Director, Mirrabooka Investments | 03 Nov 2020 |
